Similar articles for PMID: 23888060

Year	Number of Results
2004	1
2006	3
2007	3
2008	5
2009	4
2010	10
2011	13
2012	14
2013	10
2014	4
2015	5
2016	6
2017	8
2018	2
2019	4
2020	4
2021	4
2022	3
2023	2
2024	0

1

Pharmacometabonomics and personalized medicine.

Everett JR, Loo RL, Pullen FS. Everett JR, et al. Ann Clin Biochem. 2013 Nov;50(Pt 6):523-45. doi: 10.1177/0004563213497929. Epub 2013 Jul 25. Ann Clin Biochem. 2013. PMID: 23888060 Review.

2

Pharmacometabonomics in humans: a new tool for personalized medicine.

Everett JR. Everett JR. Pharmacogenomics. 2015;16(7):737-54. doi: 10.2217/pgs.15.20. Epub 2015 May 1. Pharmacogenomics. 2015. PMID: 25929853 Review.

3

From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine.

Everett JR. Everett JR. Front Pharmacol. 2016 Sep 8;7:297. doi: 10.3389/fphar.2016.00297. eCollection 2016. Front Pharmacol. 2016. PMID: 27660611 Free PMC article. Review.

4

Pharmacometabonomics: The Prediction of Drug Effects Using Metabolic Profiling.

Everett JR. Everett JR. Handb Exp Pharmacol. 2019;260:263-299. doi: 10.1007/164_2019_316. Handb Exp Pharmacol. 2019. PMID: 31823071 Review.

5

Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy.

Nicholson JK, Everett JR, Lindon JC. Nicholson JK, et al. Expert Opin Drug Metab Toxicol. 2012 Feb;8(2):135-9. doi: 10.1517/17425255.2012.646987. Epub 2012 Jan 17. Expert Opin Drug Metab Toxicol. 2012. PMID: 22248264

6

NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.

Everett JR. Everett JR. Prog Nucl Magn Reson Spectrosc. 2017 Nov;102-103:1-14. doi: 10.1016/j.pnmrs.2017.04.003. Epub 2017 May 6. Prog Nucl Magn Reson Spectrosc. 2017. PMID: 29157489 Review.

7

Pharmacometabonomics as an effector for personalized medicine.

Nicholson JK, Wilson ID, Lindon JC. Nicholson JK, et al. Pharmacogenomics. 2011 Jan;12(1):103-11. doi: 10.2217/pgs.10.157. Pharmacogenomics. 2011. PMID: 21174625 Review.

8

[Pharmacometabonomics - the novel way to personalized drug therapy].

Maslov DL, Balashova EE, Lokhov PG, Archakov AI. Maslov DL, et al. Biomed Khim. 2017 Mar;63(2):115-123. doi: 10.18097/PBMC20176302115. Biomed Khim. 2017. PMID: 28414282 Review. Russian.

9

Metabolomics enables precision medicine: "A White Paper, Community Perspective".

Beger RD, Dunn W, Schmidt MA, Gross SS, Kirwan JA, Cascante M, Brennan L, Wishart DS, Oresic M, Hankemeier T, Broadhurst DI, Lane AN, Suhre K, Kastenmüller G, Sumner SJ, Thiele I, Fiehn O, Kaddurah-Daouk R; for “Precision Medicine and Pharmacometabolomics Task Group”-Metabolomics Society Initiative. Beger RD, et al. Metabolomics. 2016;12(10):149. doi: 10.1007/s11306-016-1094-6. Epub 2016 Sep 2. Metabolomics. 2016. PMID: 27642271 Free PMC article.

10

[Progress in the personalized medicine using pharmacometabonomics].

Huang Q, A JY, Zhou GH. Huang Q, et al. Yao Xue Xue Bao. 2014 Nov;49(11):1491-7. Yao Xue Xue Bao. 2014. PMID: 25757272 Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year